Parasitic Infections in HIV-Infected Patients

  • Authors: José M. Miró, MD, PhD; Miriam J. Álvarez-Martínez, MD, PhD (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/20/21 (What's New)

Summary

  • OIs remain common in settings where ART is not widely available, in patients with undiagnosed HIV disease, and in patients who fail therapy due to drug resistance, nonadherence, or intolerance
  • Guidelines on preventing and treating OIs in patients with HIV are published by the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America (Management Guidelines)[CDC OI] and the European AIDS Clinical Society (Management Guidelines)[EACS]
  • The authors also direct Spanish-speaking clinicians to the guideline of the Grupo de Estudio de Sida (GESIDA) on the treatment of OIs (Management Guidelines)[GESIDA OI]

Action required

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.